Trial intelligence / Profile preview

Topical Glaucoma Therapy and Tear Film Stability

NCT01746602Phase 3Terminated

Sponsor
Medical University of Vienna
Start
Jul 2011
Primary completion
Sep 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of timolol in Glaucoma, sponsored by Medical University of Vienna. Started Jul 2011; status: terminated.

02

Drugs

timolol
03

Conditions

Glaucoma

Beyond the preview

Go deeper on NCT01746602.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01746602.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call